News and updates

Recent events

  • 18-19 November 2025

    Avenir was pleased to co-sponsor an invitation-only event bringing together policymakers, operators, investors, researchers, and ecosystem partners to take actionable steps toward improving access to clinical AI technology in underserved settings. Avenir CEO gave opening remarks and spoke on panels including lessons for AI from global health financing, and brand equity for clinical AI in global health.

    Read our LinkedIn posts here and here

  • 6 November 2025

    Avenir was pleased to be at the 26th Annual HBS Healthcare Alumni Association Meeting in Cambridge, where leaders across healthcare, life sciences, policy, and investment gather to exchange insights, spark collaborations, and shape the future of the industry. Avenir CEO gave opening remarks for keynote speaker and women’s health activist Christy Turlington Burns, and later moderated a panel on women’s health with investors and operators Laura Rippy, Alex DeLaite, and Neel Shah.

    Read more at the event website or our LinkedIn posts here and here.

  • We were pleased to be invited back to the Datavant Future of Health Data Summit, where leaders across policy, science, industry, and tech will convene to explore how health data can transform patient outcomes and the future of care.

    Read more about the event here.

  • We were pleased to reconnect with colleagues at WHS 2025 in Berlin, where global leaders, innovators, and change-makers will come together to shape the future of global health, innovative financing, and strategic partnerships.

    Read more about WHS here.

Recent writing

Recent courses and webinars

  • 24 February 2026

    As an invited lecturer to Dartmouth’s Master in Public Health, Avenir CEO will lead students through an introduction to market access and market shaping in global health, followed by a negotiation simulation.

  • December 2025

    Avenir was invited to guest speak for the Health Incubator Helsinki founder cohort on investor storytelling and negotiation strategies when building your health tech / biotech business.

    To read more about the amazing work HIH does, click here.

  • November 2025

    As an invited lecturer to Professors Kendall Hoyt and Barry Schweitzer’s course on “Vaccines, Drugs, and Entrepreneurship,” Avenir CEO lectured on the transactions that are required to bring a product to LMIC markets, and led a negotiation simulation for students to try landing realistic deals between parties.

    Read about the course here and our LinkedIn post here.

  • February 2025

    Avenir CEO was invited to speak in a course called Technology and Biosecurity led by Professor Kendall Hoyt at the Thayer School of Engineering. The lecture covered global health partnerships, commercial strategy, and stakeholder alignment.

    Read more about the course here and our LinkedIn post here.

  • 11 June

    It was a pleasure to moderate a panel called “From Concept to Company: Powering Early Stage Biotech” with biotech leaders across operating companies, investment firms, and the essential operational and infrastructure backbone.

    Read more about the event here and our LinkedIn post here.

Resources

Interested in learning more about the business of global health? These are some helpful places to get started.